[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-345026-105":59,"doc-detail-345026-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","mechanistic-insights-and-clinical-implications-of-rna-binding-proteins-in-prostate-cancer","Mechanistic insights and clinical implications of RNA-binding proteins in prostate cancer","","Prostate cancer (PCa) remains a leading cause of cancer morbidity and mortality in men worldwide. RNA-binding proteins (RBPs) regulate gene expression by controlling RNA stability, localization, alternative splicing, and translation. Dysregulated RBP expression contributes to PCa tumorigenesis, progression, and treatment resistance. RBPs influence key malignant cell behaviors including proliferation, apoptosis, migration, invasion, and metastasis. This review summarizes RBP biological functions, mechanisms in PCa, their roles in signaling and androgen receptor (AR) signaling, and clinical applications as prognostic/diagnostic biomarkers and potential therapeutic targets.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/mechanistic-insights-and-clinical-implications-of-rna-binding-proteins-in-prostate-cancer/345026/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/mechanistic-insights-and-clinical-implications-of-rna-binding-proteins-in-prostate-cancer/345026.png","ImageObject",300,407,{"name":92,"@type":93},"Ivy","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How do RNA-binding proteins (RBPs) affect gene regulation in prostate cancer?","Question",{"text":112,"@type":113},"RBPs regulate gene expression by binding RNAs and influencing stability, localization, alternative splicing, and translation. Aberrant RBP expression drives cancer-related processes in PCa.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What biological processes in prostate cancer are influenced by RBPs?",{"text":117,"@type":113},"RBPs can modulate proliferation, apoptosis, migration, invasion, and metastasis. They also contribute to tumorigenesis and progression in PCa.",{"name":119,"@type":110,"acceptedAnswer":120},"How might RBPs be used clinically in prostate cancer?",{"text":121,"@type":113},"The review highlights RBPs as prognostic and diagnostic biomarkers in PCa and discusses their potential as therapeutic targets. It also emphasizes their involvement in signaling pathways and androgen receptor (AR) signaling.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},345026,1790186492,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},549758252649,"https://ap-avatar.wpscdn.com/avatar/8000253669c5317157?_k=1778319167496531819","Javankiani etal. Discover Oncology (2026) 17:489  \n[https://doi.org/10.1007/s12672-026-04467-6](https://doi.org/10.1007/s12672-026-04467-6)  \nDiscover Oncology  \nREVIEW Open Access  \nMechanistic insights and clinical implications  of RNA-binding proteins in prostate cancer  \nSepide Javankiani1†, Masoud Khodarahmi2†, ForoozanYarahmadi2, Seyedeh Tarlan Mirzohreh2, Saman Soltani Moghadam2, Pegah Kavousinia2, Sadegh Moradi2, Nahal Aghajamal Avval2, Mandana Baghdadi2, Nasibeh Sargazi Moghaddam2, Mahyar Khanlari Goodarzi2, Neda Zamen Milani3, Faeze Ahmadi Beni4* and Qumars Behfar1,2*  \n†Sepide Javankiani and Masoud Khodarahmi have contributed equally to this work.  \n*Correspondence:  \nFaeze Ahmadi Beni [Faezeahmadi137@yahoo.com](Faezeahmadi137@yahoo.com)[ ](Faezeahmadi137@yahoo.com)Qumars Behfar [q_behfar@yahoo.com](q_behfar@yahoo.com)  \nFull list of author information is available at the end of the article  \nAbstract  \nProstate cancer (PCa) remains one of the most common cancers and the second leading cause of cancer-related morbidity in men worldwide. RNA-binding proteins (RBPs) have emerged as crucial regulators of gene expression via binding to RNAsand influencing their stability, localization, alternative splicing, and translation. Aberrant expression of RBPs causes various diseases, including cancer. Growing evidence has indicated that RBPs participate in PCa tumorigenesis, progression, and therapeutic resistance. Specifically, RBPs can regulate cancerous behaviors of the cells, including proliferation, apoptosis, migration, invasion, and metastasis. This review aims to provide a comprehensive overview of the biological functions of RBPs, as well as the mechanisms by which they contribute to PCa, highlighting their crucial role in regulating signaling pathways and AR signaling. Furthermore, we discuss the clinical applications of RBPs in PCa as both prognostic and diagnostic biomarkers, as well as their potential as therapeutic targets.  \nKeywords Prostate cancer, RNA binding proteins, Tumorigenesis, Tumor resistance, Biomarker, RNA-protein interaction  \n1 Introduction  \nProstate cancer (PCa) is ranked as one of the most frequent cancers and the second leading cause of cancer-related deaths in men globally [1]. Age is the main risk factor for PCa, and the possibility of occurrence of the disease increases significantly as men get older. PCa is most common among men over 55, emphasizing the substantial impact of this cancer on the elderly male population [2]. PCa accounts for 7.3% of cancer incidence and 4.1% of mortality globally [3]. In 2025, about 313,780 new cases of PCa and 35770 PCa-related deaths were reported in the United States [4]. In recent decades, the incidence of PCa has been increasing in developing countries, exerting a severe burden on patients, families, and public health systems [5]. PCa is classified into aggressive and indolent categories according to its growth characteristics. The fast growth of the tumor accompanies an aggressive form, and the patients are advised to receive surgery or  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from","cbCain8fvlFQixGr","https://ap.wps.com/l/cbCain8fvlFQixGr","pdf",1869048,28,"English","# Introduction\n## Risk factors and epidemiology\n## Disease classification and diagnosis\n## Current treatment landscape and challenges\n# Abstract\n## Role of RNA-binding proteins in gene regulation\n## Links between RBPs and PCa progression\n## Therapeutic resistance and clinical biomarker potential","[{\"question\":\"How do RNA-binding proteins (RBPs) affect gene regulation in prostate cancer?\",\"answer\":\"RBPs regulate gene expression by binding RNAs and influencing stability, localization, alternative splicing, and translation. Aberrant RBP expression drives cancer-related processes in PCa.\"},{\"question\":\"What biological processes in prostate cancer are influenced by RBPs?\",\"answer\":\"RBPs can modulate proliferation, apoptosis, migration, invasion, and metastasis. They also contribute to tumorigenesis and progression in PCa.\"},{\"question\":\"How might RBPs be used clinically in prostate cancer?\",\"answer\":\"The review highlights RBPs as prognostic and diagnostic biomarkers in PCa and discusses their potential as therapeutic targets. It also emphasizes their involvement in signaling pathways and androgen receptor (AR) signaling.\"}]","Mechanistic insights and clinical implications of RNA-binding proteins in prostate cancer | PDF",1790056261,71,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/742749bb3bbf92809523d937577c5fb5.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f3e0915f07f875890fb7deb806fe2eda.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b4587f06f8f5a656c73cfbe2ca29e00f.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f566cb1ca57d74fc93a840d8d5ad1e00.webp",980,1306]